Synthetic biotechnology company//$340M+ annual revenue (FY21)//NasdaqExecutive Leadership/ManagementScaling and developing legal department to suit content and geographic growth across commercial, operations and corporate functions. Spearheading company-wide diversity, equity & inclusion efforts and mentorship program. Founding Legal Team Externship Program in collaboration with Northwestern Pritzker School of Law (Bay Area campus).Corporate Governance/RegulatoryInstituting best practices for the Board of Directors and its committees, including coordination of deliverables by executive leadership. Leading on diversifying Board membership. Managing key regulatory issues across multiple geographies; including business growth in China, and the launch of novel sustainable ingredient businesses and a vaccine platform partnership.Transactions/Securities/ComplianceNegotiating major corporate M&A and commercial transactions, complex securities offerings and financial transactions. Managing external reporting (SEC and Nasdaq) and related public disclosure issues; corporate litigation and government investigations. Compliance Officer; establishing compliance program, with related policies and employee training.Intellectual PropertyDeveloping company IP Policy. Directing patent and trademark portfolio strategies. Improving coordination of R&D and Product Development departments with Business Development and Operations departments.

Advertising technology company//$2.3B annual revenue (Nasdaq)Executive ManagementBuilt and developed global legal department, with distinct teams covering commercial, corporate and compliance functions. Developed management layers and individual leadership skills of legal department. Spearheaded mentoring & DEI programs within executive management and across the company.Securities/CorporateLed the transition from Foreign Private Issuer to U.S. Domestic Registrant, including oversight of SEC and Nasdaq filings, coordination under French laws, and management of transverse internal contributors and external resources. Built separate U.S. and French corporate teams to manage coordinated analysis of requirements under both legal systems. Managed governmental inquiries and corporate litigation.Corporate GovernanceInstituted best practices for the Board of Directors and its committees, under both French and U.S. requirements and governance standards. Contributed to diversification of Board membership. Managed external advisors, and wind-down of U.S. Advisory Board.Commercial/Intellectual PropertyBuilt team of lawyers for 3 geographic regions (Americas, EMEA, APAC). Instituted development of universal T&Cs for each product roll-out, specific to each applicable geography. Instituted sales team training processes, coordinated among legal, data privacy and product departments. Spearheaded development of global IP strategy. Managed industry-leading commercial litigation and IP litigation.ComplianceDrafted global anti-corruption policy and developed geographic-specific procedures, and managed high-risk geography (BRIC) training program. Created delegation of authority policy with SOX-compliant internal tracking procedures. Built Compliance function, instituting best-in-class policies and procedures (OFAC, Whistleblowing, Gifts & Hospitality).

Medical technology company//$17B annual revenue (NYSE)SecuritiesManaged filings with, and inquiries from, the SEC; reviewed all Investor Relations presentations and press releases; drafted new Reg FD Policy and prepared related training presentations; managed quarterly black-out periods under Insider Trading Policy; drafted quarterly litigation disclosure and revised related SOX control processes.Corporate GovernanceManaged quarterly meetings of the Board’s Audit Committee; created and managed the Board’s Finance Committee with the Treasurer; researched governance issues, drafted memoranda for Nominating & Corporate Governance Committee (e.g., Board rotation and terms; CEO succession plans); spearheaded creation of company OFAC policy; created and coordinated company social media policy.Treasury/FinanceNegotiated annual revolving debt facility, other debt documents. Managed cash repatriation (with Tax & Treasury) and external auditor.ManagementCo-supervised corporate paralegal.

Financial services company//$6.4B annual revenue (NYSE) Corporate Governance/Bank Regulatory/CorporateLed cross-departmental working group for the Troubled Assets Relief Program (“TARP”); response to TARP Special Inspector General audits/inquiries; NY Federal Reserve Bank Corporate Governance Plan; supervised CIT PAC; Distressed Debt Investment Policy & Procedures; SOX-compliant Contract Monitoring Policy; 50-state licensing survey; contract negotiations (Tax, IT, HR, Compliance).Corporate M&A/M&A Advisory Negotiated corporate M&A and M&A Advisory matters. Drafted M&A Advisory Fairness Opinion Committee procedures and served as Committee representative.ManagementSupervised business unit attorneys on all M&A matters; trained M&A Advisory attorney; managed M&A and securities paralegals.

Negotiated Capital Markets transactions; created M&A Advisory form documents; developed Distressed Debt Procedures.

Private art financing groupManaged all legal and compliance matters, bankruptcy and litigation, trademarks, loan negotiations, press releases; HR management.

Home art gallery, based out of apartment on Upper West Side; featuring contemporary international artists specializing in painting, works on paper and small-scale sculpture.

Media, entertainment conglomerate//$19.5B annual revenue (NYSE)Responsible for U.S. securities matters (SEC filings & NYSE compliance), M&A matters, corporate governance; corporate communications and Investor Relations, litigation matters; liaison between New York and Paris legal departments.

Financial services company//$14.6B annual revenue (NYSE)Responsible for acquisitions (stock, asset and joint venture) and dispositions for Citigroup businesses in EMEA.

U.S. securities point-person on U.S. deals for French and European clients; U.S. securities and M&A transactions; commercial financings.

Paris: all U.S.-focused deals; establishment of Russian funds; a Russian privatization.New York: securities offerings (IPOs, secondary/shelf offerings, private placements, exchange offers), private M&A deals and general corporate matters.